Impact of Early Postnatal Sodium Supplementation on Weight Gain in Very Low Birth Weight Infants
Overview
- Phase
- Phase 4
- Intervention
- Sodium chloride
- Conditions
- Extreme Immaturity
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Enrollment
- 53
- Locations
- 1
- Primary Endpoint
- Weight Gain at Six Weeks of Age
- Status
- Terminated
- Last Updated
- 5 years ago
Overview
Brief Summary
Adequate growth during the neonatal period is critical for optimal long term outcomes. Despite maximal calorie intake, sixty percent of very low birth weight infants still fail to thrive suggesting that factors other than total calorie intake are important in ensuring consistent weight gain. Several reports have indicated a positive sodium balance is critical in ensuring good weight gain in very low birth weight infants, however these infants are susceptible to low serum sodium concentrations. Urine sodium values are sometimes used to diagnosis of hyponatremia or negative sodium balance after the first two weeks of life, but there is no evidence for this practice in preterm neonates. Our central hypothesis is that early supplementation with sodium will ensure positive sodium balance in very low birth weight infants and will result in optimal weight gain and enhanced long term outcomes. Secondarily we hypothesize that low sodium concentrations in the urine will not correlate with low serum sodium values.
Detailed Description
This is a randomized, blinded, placebo-controlled trial in infants born at less than 32 weeks gestation, who are admitted to the Newborn Intensive Care Unit at University of Cincinnati Medical Center, Cincinnati, Ohio. Infants are randomized to receive either 4 meq/kg/day supplemental sodium or an equal amount of sterile water on days of life 7-35. Institutional data from 2008 revealed that a sample size of 56 infants completing the study will detect a 15% difference in the primary outcome of weight gain with 80% power and an alpha error of 0.05. Allowing that 33% drop-out rate (infants may be transferred to another hospital, expire, or be discharged prior to day of life 35), we choose to randomize 75 infants. Calorie intake, serum sodium, weight gain, urine sodium were monitored weekly till 35 days of life or discharge. Infants were assessed for common morbidities associated with prematurity including bronchopulmonary dysplasia, systemic hypertension, late-onset sepsis, necrotizing enterocolitis and retinopathy of prematurity.
Investigators
Eligibility Criteria
Inclusion Criteria
- •infants born at less than 32 weeks postmenstrual age
Exclusion Criteria
- •infants with major malformations deemed incompatible with life disease states characterized by edema renal failure, defined as an increase in serum creatinine by 0.5 mg/dl/day or urine output less than 0.5 ml/kg/hour
Arms & Interventions
Sodium chloride
Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.
Intervention: Sodium chloride
sterile water
Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.
Intervention: Placebo
Outcomes
Primary Outcomes
Weight Gain at Six Weeks of Age
Time Frame: Six weeks of age
Average weight gain in g/kg/day and also as a % birthweight over the first six weeks of the study will be compared between the two study arms
Secondary Outcomes
- Body Length at Six Weeks of Age(six weeks of age)
- Head Circumference(six weeks of age)
- Mean Systolic Blood Pressure(36 weeks post-conceptual age)
- Chronic Diuretic Therapy(patients will be followed during birth hospital stay; an expected average of 3 months of age)
- Late-onset Sepsis(patients will be followed during birth hospitalization; an expected average of 3 months of age)
- Necrotizing Enterocolitis(patients will be followed during birth hospitalization; an expected average of 3 months of age)
- Chronic Lung Disease(36 weeks post-mentrual age)
- Mortality(patients will be followed during birth hospitalization; an expected 3 months of age)
- Patent Ductus Arteriosus(After the second week of life)